Exploration of patient risk profiles for adverse drug reactions – Establishment of a care cohort of patients under complex drug therapies

Exploration of patient risk profiles for adverse drug reactions – Establishment of a care cohort of patients under complex drug therapies - RISKPAT

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034098

Enrollment

1000

Registered

2025-03-07

Start date

2024-10-09

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Y57.9

Interventions

Group 1: Patients eligible for clinical pharmacological therapy consultation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Treatment involves a specialized, complex drug therapy as determined by a specialist, requiring individualized clinical pharmacological consultation

Exclusion criteria

Exclusion criteria: Lack of capacity to consent

Design outcomes

Primary

Measure	Time frame
Identification of risk profiles for adverse drug reactions in patients eligible for clinical pharmacological therapy consultation	—

Secondary

Measure	Time frame
Reduced incidence of adverse drug reactions in patients undergoing complex drug therapy	—

Countries

Germany

Contacts

Public ContactKatja Just

Institut für Klinische Pharmakologie

klinischepharmakologie@ukaachen.de+49 241 80 89131

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026